Irregularities found in samples of lethal drug

    By Shan Juan (China Daily)
    Updated: 2008-06-03 07:10

    Irregularities have been found in some samples of the drug linked to six deaths in eastern China, the State Food and Drug Administration (SFDA) said Monday in a statement on its website.

    Between May 22 and May 28, six people died at the No 2 Hospital affiliated with Nanchang University in Jiangxi province, after being injected with immune globulin, which is derived from blood plasma, the Xinhua News Agency reported Monday.

    The drug is widely used to enhance the immunity of critically ill patients, such as those suffering from cancer.

    An investigation into the medicine, produced by Jiangxi Boya Bio-Pharmaceutical Co, is ongoing, Yan Jiangying, spokeswoman for the SFDA told China Daily, without giving details of the irregularities mentioned in the statement.

    "It will take time to determine the root cause because of the complicated lab tests," she said, while suggesting there was a possibility that counterfeit drugs may have been to blame.

    The SFDA has ordered drug suppliers and hospitals to suspend the sale and use of all immune globulin products labeled or sold as products from the Jiangxi company, which was last week ordered to recall the problem drugs, Yan said.

    "The provincial police are also involved in the investigation," she said, adding that more information will be published as soon as possible.

    There have been no reports of other fatalities, even at hospitals using drugs from the same batch, she said.

    Yu Feng, spokeswoman for the hospital where the six people died, told China Daily they were all inpatients who were critically ill.

    "Nearly all of them died suddenly, after being on the medicine for two to three days and not showing any adverse signs," she said.

    The hospital last month bought 500 units of the drug, she said, and six of the seven patients who had been injected with it died.

    "We are puzzled by the deaths, as our hospital has been using the drug produced by the company for years, without any adverse effects being detected," Yu Feng said.

    The hospital uses immune globulin supplied only by Jiangxi Boya, which is an approved company and therefore overseen by the SFDA, she said.

    Also, as one of the main hospitals in the city, "we strictly abide by drug safety regulations in terms of their proper purchase and use," she said.

    In July of last year, the SFDA revoked the production license of Guangdong Baiyi Pharmaceutical Co, which made immune globulin products from infected blood, Xinhua reported.

    Some patients injected with the drug tested positive for hepatitis C.

    In an effort to increase drug safety, the SFDA in January also began compulsory testing on all batches of blood products and stationed inspectors at each of the country's 33 blood-related drug producers.



    Top China News  
    Today's Top News  
    Most Commented/Read Stories in 48 Hours
    久久精品中文字幕一区| 最近更新免费中文字幕大全 | 亚洲日韩激情无码一区| 精品久久久中文字幕人妻| 无码aⅴ精品一区二区三区浪潮| 中文字幕在线观看亚洲| 50岁人妻丰满熟妇αv无码区 | 无码粉嫩小泬无套在线观看| 亚洲国产精品无码久久久久久曰 | 中文字幕av无码专区第一页| 中文字幕乱偷无码AV先锋| 人妻无码视频一区二区三区| 日本中文字幕在线视频一区| 无码色AV一二区在线播放| 精品无码久久久久国产| 亚洲av中文无码乱人伦在线播放| 亚洲成A人片在线观看中文| 亚洲精品中文字幕无码蜜桃| 无码AV动漫精品一区二区免费| 无码孕妇孕交在线观看| 高清无码中文字幕在线观看视频| 亚洲中文字幕久久精品无码APP | 中文字幕无码一区二区免费| 亚洲欧洲中文日韩久久AV乱码| 国产乱码精品一区二区三区中文| 久久精品一区二区三区中文字幕| 日本精品久久久中文字幕| 久久中文骚妇内射| 狠狠干中文字幕| 最近中文字幕高清中文字幕无| 婷婷中文娱乐网开心| 精品无码久久久久久久动漫| 免费无码国产在线观国内自拍中文字幕| 亚洲综合无码精品一区二区三区| 一二三四在线观看免费中文在线观看| 中文字幕一区在线观看视频| 色综合中文综合网| 欧美中文字幕无线码视频| 中文无码熟妇人妻AV在线| 无码人妻精品一区二区三区蜜桃| 日本爆乳j罩杯无码视频|